Status:

COMPLETED

EEG Monitoring for PERFormance Anticipation

Lead Sponsor:

Hospices Civils de Lyon

Conditions:

Healthy

Eligibility:

All Genders

18-70 years

Phase:

NA

Brief Summary

Identify, characterize and then validate electrophysiological markers linking electrophysiological cerebral activity and performance in cognitive and physical fatigability in humans. To do this, nonin...

Eligibility Criteria

Inclusion

  • Inclusion Criteria MGPFco group:
  • Adult subjects, male or female, right-handed or left-handed, from 18 years up to 70 years;
  • Having duly completed the entire confidential medical questionnaire;
  • Written consent of free, informed and express participation;
  • No hearing problems;
  • Having normal or corrected vision;
  • Affiliation to a Social Security scheme.
  • Inclusion Criteria MGPFph group:
  • Adult subjects, male or female, right-handed or left-handed, from 18 years up to 35 years;
  • Practicing at least five hours of sports per week;
  • Presenting a certificate of no contraindication to an exercise test, intense sports practice or an energy sport in competition of the current year;
  • Having duly completed the entire confidential medical questionnaire;
  • Without cardiovascular or motor disability;
  • Without tumoral, inflammatory, cardiac, pulmonary, renal, digestive (malabsorption syndrome) or liver disease;
  • Written consent of free, informed and express participation;
  • Affiliation to a Social Security scheme.
  • Exclusion Criteria:
  • Pregnant women, nursing mothers or those of childbearing age without contraception
  • Persons under guardianship, curatorship or any other administrative or judicial measure of deprivation of liberty or of liberty
  • Persons protected by the law
  • Persons who have performed a maximum stress test within 15 days of the date of inclusion,
  • In the course of drug treatments against indicated for the protocol (treatment for neurological diseases, psychiatric ...).
  • Metal implants incompatible with MRI (for the subjects concerned, see appendices)
  • Metallic implants incompatible with the MEG (for the subjects concerned, see appendices)

Exclusion

    Key Trial Info

    Start Date :

    May 30 2013

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    May 31 2018

    Estimated Enrollment :

    169 Patients enrolled

    Trial Details

    Trial ID

    NCT03233282

    Start Date

    May 30 2013

    End Date

    May 31 2018

    Last Update

    October 3 2025

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Hospices Civils de Lyon, HFME

    Bron, France, 69500